China Resources Sanjiu Medical & Pharmaceutical Yönetim

Yönetim kriter kontrolleri 2/4

Şu anda CEO hakkında yeterli bilgiye sahip değiliz.

Anahtar bilgiler

İcra Kurulu Başkanı

n/a

Toplam tazminat

CEO maaş yüzdesi	n/a
CEO görev süresi	no data
CEO sahipliği	n/a
Yönetim ortalama görev süresi	5yrs
Yönetim Kurulu ortalama görev süresi	4.1yrs

Son yönetim güncellemeleri

Recent updates

CEO

China Resources Sanjiu Medical & Pharmaceutical CEO'su yok ya da onlar hakkında elimizde veri yok.

Liderlik Ekibi

İsim	Pozisyon	Görev süresi	Tazminat	Sahiplik
Wen Duo Wu	President & Director	no data	CN¥1.88m	Veri yok
Zheng Liang	CFO & Secretary of the Board of Directors	5yrs	CN¥2.49m	0.013% CN¥ 7.8m
Hui Zhou	VP, Secretary	22.8yrs	CN¥3.10m	0.013% CN¥ 8.1m
Liang Wang	Vice President	no data	CN¥2.67m	0.010% CN¥ 6.1m

5.0yrs

Ortalama Görev Süresi

47.5yo

Ortalama Yaş

Deneyimli Yönetim: 000999 'un yönetim ekibi deneyimli ve deneyimlidir ( 5 yıldır).

Yönetim Kurulu Üyeleri

İsim	Pozisyon	Görev süresi	Tazminat	Sahiplik
Wen Duo Wu	President & Director	no data	CN¥1.88m	Veri yok
Hui Zhou	VP, Secretary	19.5yrs	CN¥3.10m	0.013% CN¥ 8.1m
Huawei Qiu	Chairman	7.1yrs	CN¥4.61m	0.019% CN¥ 11.8m
Fang Xu	Independent Director	6.5yrs	CN¥150.00k	Veri yok
Xingtian Yao	Independent Director	6.5yrs	CN¥150.00k	Veri yok
Ran Tao	Chairman of the Supervisory Board	5.9yrs	Veri yok	Veri yok
Na Tang	Non-Employee Supervisor	5.3yrs	Veri yok	Veri yok
Qiang Zhang	Independent Director	1.1yrs	Veri yok	Veri yok
Xiaosong Bai	Non-Independent Director	2.6yrs	Veri yok	Veri yok
Xingpin Cui	Non-Independent Director	2.6yrs	Veri yok	Veri yok
Yang Don	Director	2.9yrs	CN¥150.00k	Veri yok
Shutian Yu	Director	2yrs	Veri yok	Veri yok

4.1yrs

Ortalama Görev Süresi

56yo

Ortalama Yaş

Deneyimli Yönetim Kurulu: 000999 'nin yönetim kurulu üyeleri deneyimli olarak kabul edilir (ortalama görev süresi 5.6 yıldır).

China Resources Sanjiu Medical & Pharmaceutical Yönetim

Yönetim kriter kontrolleri 2/4

Anahtar bilgiler

Son yönetim güncellemeleri

High number of new directors

China Resources Sanjiu Medical & Pharmaceutical Co., Ltd., Annual General Meeting, Apr 19, 2024

High number of new directors

China Resources Sanjiu Medical & Pharmaceutical Co., Ltd., Annual General Meeting, Jun 23, 2022

High number of new directors

High number of new directors

Recent updates

Third quarter 2024 earnings released: EPS: CN¥0.45 (vs CN¥0.41 in 3Q 2023)

Investor sentiment improves as stock rises 25%

China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. to Report Q3, 2024 Results on Oct 26, 2024

Investor sentiment deteriorates as stock falls 17%

Second quarter 2024 earnings released: EPS: CN¥0.80 (vs CN¥0.57 in 2Q 2023)

China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. to Report First Half, 2024 Results on Aug 24, 2024

Dividend increased to CN¥1.50

China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. Announces Final Profit Distribution Plan to Be Implemented on A Shares for the Year 2023, Payable on 14 June 2024

High number of new directors

China Resources Sanjiu Medical & Pharmaceutical Co., Ltd., Annual General Meeting, Apr 19, 2024

Full year 2023 earnings released: EPS: CN¥2.90 (vs CN¥2.48 in FY 2022)

China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. to Report Fiscal Year 2023 Results on Mar 23, 2024

Third quarter 2023 earnings released: EPS: CN¥0.53 (vs CN¥0.53 in 3Q 2022)

Second quarter 2023 earnings released: EPS: CN¥0.75 (vs CN¥0.60 in 2Q 2022)

China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. Announces Implementation of Cash Dividend for 2022, Payable on 15 June 2023

Now 22% undervalued

Full year 2022 earnings released: EPS: CN¥2.48 (vs CN¥2.09 in FY 2021)

Now 20% undervalued

China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. Provides Earnings Guidance for the Year Ended 31 December 2022

Investor sentiment improved over the past week

High number of new directors

Third quarter 2022 earnings released: EPS: CN¥0.53 (vs CN¥0.39 in 3Q 2021)

Investor sentiment improved over the past week

Second quarter 2022 earnings released: EPS: CN¥0.60 (vs CN¥0.73 in 2Q 2021)

China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. Announces Final Profit Distribution Plan to Be Implemented on A Shares for the Year 2021, Payable on 12 August 2022

China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. Approves Cash Dividend for the Year 2021

China Resources Sanjiu Medical & Pharmaceutical Co., Ltd., Annual General Meeting, Jun 23, 2022

China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. (SZSE:000999) agreed to acquire 28% stake in KPC Pharmaceuticals, Inc. (SHSE:600422) from Holley Pharmaceutical Group Co., Ltd and Holley Group Company Limited for CNY 2.9 billion.

First quarter 2022 earnings released: EPS: CN¥0.86 (vs CN¥0.66 in 1Q 2021)

High number of new directors

High number of new directors

Investor sentiment improved over the past week

China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. Proposes Cash Dividend as of 31 December 2021

Full year 2021 earnings: EPS in line with expectations, revenues disappoint

China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. Announces Board Elections

High number of new directors

Investor sentiment improved over the past week

Third quarter 2021 earnings released: EPS CN¥0.39 (vs CN¥0.51 in 3Q 2020)

Investor sentiment improved over the past week

Second quarter 2021 earnings released: EPS CN¥0.73 (vs CN¥0.54 in 2Q 2020)

China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. Approves Final Cash Dividend for 2020

First quarter 2021 earnings released: EPS CN¥0.66 (vs CN¥0.54 in 1Q 2020)

China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. Proposes Cash Dividend for the Year December 31, 2020

Full year 2020 earnings released: EPS CN¥1.63 (vs CN¥2.16 in FY 2019)

China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. to Report Fiscal Year 2020 Results on Mar 19, 2021

New 90-day low: CN¥24.96

Third quarter earnings released

Third-quarter earnings released: Revenue misses expectations

New 90-day low: CN¥26.02

New 90-day low - CN¥27.00

Earnings released

China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. to Report First Half, 2020 Results on Aug 26, 2020

CEO

Liderlik Ekibi

Ortalama Görev Süresi

Ortalama Yaş

Yönetim Kurulu Üyeleri

Ortalama Görev Süresi

Ortalama Yaş